Return to homepagePandemic Pact

COVID-19 Therapeutics II: Demonstrating the efficacy and safety of tiprelestat for the treatment of COVID-19 (COMCOVID Study)

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:1 publications

Grant number: 16LW0151

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2024

  • Known Financial Commitments (USD)

    $11,214,955.23

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Research Location

    Germany

  • Lead Research Institution

    tiakis Biotech AG

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

1 Publication linked via Europe PMC

Last Updated:3 days ago

View all publications at Europe PMC

Tiprelestat for treatment of hospitalized COVID-19: results of the double-blind randomized placebo-controlled COMCOVID trial.